Ms. Gibson, author of the book China Rx: Exposing the Risks of America’s Dependence on China for Medicine, told WCNC that because China has already stopped companies that make surgical masks and protective medical gear from exporting those items to other countries, it is likely the country would do the same for drugs if the coronavirus outbreak doesn’t taper.
China produces most of the active pharmaceutical ingredients the U.S. uses to make generic drugs. Generic drugs account for 90 percent of the drugs the U.S. uses, Ms. Gibson said.
“China makes about 90 percent of the production for the medicines for people who might end up in the hospital for coronavirus,” she told WCNC.
She added that the U.S. doesn’t have the capacity to quickly produce the drugs a hospital would need if a severe coronavirus outbreak happened in the U.S.
Read the full article here.
More articles on pharmacy:
21 states reject $18B opioid settlement offer from McKesson, Cardinal, AmerisourceBergen
BCBS responds to physician pushback on mail-order pharmacy plan
The 20 most expensive drugs in the US in 2020
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
